Arrowhead Pharmaceuticals (ARWR) Operating Margin (2016 - 2025)
Historic Operating Margin for Arrowhead Pharmaceuticals (ARWR) over the last 16 years, with Q4 2025 value amounting to 15.46%.
- Arrowhead Pharmaceuticals' Operating Margin rose 64719400.0% to 15.46% in Q4 2025 from the same period last year, while for Dec 2025 it was 27.55%, marking a year-over-year increase of 250654300.0%. This contributed to the annual value of 11.86% for FY2025, which is 169389200.0% up from last year.
- Per Arrowhead Pharmaceuticals' latest filing, its Operating Margin stood at 15.46% for Q4 2025, which was up 64719400.0% from 17.2% recorded in Q3 2025.
- In the past 5 years, Arrowhead Pharmaceuticals' Operating Margin registered a high of 70.24% during Q1 2025, and its lowest value of 6456.48% during Q4 2024.
- Its 5-year average for Operating Margin is 774.72%, with a median of 169.48% in 2021.
- As far as peak fluctuations go, Arrowhead Pharmaceuticals' Operating Margin plummeted by -37778900bps in 2023, and later skyrocketed by 64719400bps in 2025.
- Arrowhead Pharmaceuticals' Operating Margin (Quarter) stood at 230.77% in 2021, then skyrocketed by 71bps to 67.36% in 2022, then tumbled by -5608bps to 3845.25% in 2023, then plummeted by -68bps to 6456.48% in 2024, then surged by 100bps to 15.46% in 2025.
- Its Operating Margin stands at 15.46% for Q4 2025, versus 17.2% for Q3 2025 and 596.21% for Q2 2025.